Abstract
In this chapter, you will learn how to use translocation biosensors to investigate protein functions in living cells. We here present three classes of modular protein translocation biosensors tailored to investigate: (1) signal-mediated nucleo-cytoplasmic transport, (2) protease activity, and (3) protein-protein interactions. Besides the mapping of protein function, the biosensors are also applicable to identify chemicals and/or (nano) materials modulating the respective protein activities and can also be exploited for RNAi-mediated genetic screens.
References
Knauer SK et al (2011) Bioassays to monitor Taspase1 function for the identification of pharmacogenetic inhibitors. PLoS One 6(5):e18253
Fetz V, Knauer SK, Bier C, von Kries JP, Stauber RH (2009) Translocation biosensors - cellular system integrators to dissect CRM1-dependent nuclear export by Chemicogenomics. Sensors 9:5423–5445
Hua Y et al (2014) High-content positional biosensor screening assay for compounds to prevent or disrupt androgen receptor and transcriptional intermediary factor 2 protein-protein interactions. Assay Drug Dev Technol 12(7):395–418
Korn K, Krausz E (2007) Cell-based high-content screening of small-molecule libraries. Curr Opin Chem Biol 11(5):503–510
Lundholt BK et al (2006) A simple cell-based HTS assay system to screen for inhibitors of p53-Hdm2 protein-protein interactions. Assay Drug Dev Technol 4(6):679–688
Heydorn A et al (2006) Protein translocation assays: key tools for accessing new biological information with high-throughput microscopy. Methods Enzymol 414:513–530
Loechel F et al (2007) High content translocation assays for pathway profiling. Methods Mol Biol 356:401–414
Zanella F et al (2007) An HTS approach to screen for antagonists of the nuclear export machinery using high content cell-based assays. Assay Drug Dev Technol 5(3):333–341
Fuller CJ, Straight AF (2010) Image analysis benchmarking methods for high-content screen design. J Microsc 238(2):145–161
Zhang JH, Chung TD, Oldenburg KR (1999) A simple statistical parameter for use in evaluation and validation of high throughput screening assays. J Biomol Screen 4(2):67–73
Turner JG, Dawson J, Sullivan DM (2012) Nuclear export of proteins and drug resistance in cancer. Biochem Pharmacol 83(8):1021–1032
Hutten S, Kehlenbach RH (2007) CRM1-mediated nuclear export: to the pore and beyond. Trends Cell Biol 17(4):193–201
Bier C et al (2011) The Importin-alpha/Nucleophosmin switch controls Taspase1 protease function. Traffic 12(6):703–714
Knauer SK et al (2006) The Survivin-Crm1 interaction is essential for chromosomal passenger complex localization and function. EMBO Rep 7(12):1259–1265
Knauer SK et al (2005) Translocation biosensors to study signal-specific nucleo-cytoplasmic transport, protease activity and protein-protein interactions. Traffic 6(7):594–606
Turk B (2006) Targeting proteases: successes, failures and future prospects. Nature reviews. Drug Discov 5(9):785–799
Clausen T et al (2011) HTRA proteases: regulated proteolysis in protein quality control. Nature reviews. Mol Cell Biol 12(3):152–162
Bier C et al (2011) Cell-based analysis of structure-function activity of threonine aspartase 1. J Biol Chem 286(4):3007–3017
Kar G, Gursoy A, Keskin O (2009) Human cancer protein-protein interaction network: a structural perspective. PLoS Comput Biol 5(12):e1000601
Arkin MR, Whitty A (2009) The road less traveled: modulating signal transduction enzymes by inhibiting their protein-protein interactions. Curr Opin Chem Biol 13(3):284–290
Bier C et al (2012) Allosteric inhibition of Taspase1’s pathobiological activity by enforced dimerization in vivo. FASEB J 26(8):3421–3429
Mullard A (2012) Protein-protein interaction inhibitors get into the groove. Nat Rev Drug Discov 11(3):173–175
Dudgeon DD et al (2010) Characterization and optimization of a novel protein-protein interaction biosensor high-content screening assay to identify disruptors of the interactions between p53 and hDM2. Assay Drug Dev Technol 8(4):437–458
Carry JC, Garcia-Echeverria C (2013) Inhibitors of the p53/hdm2 protein-protein interaction-path to the clinic. Bioorg Med Chem Lett 23(9):2480–2485
Rose R et al (2011) Identification and structure of small-molecule stabilizers of 14-3-3 protein-protein interactions. Angew Chem Int Ed Engl 49(24):4129–4132
Ottmann C et al (2009) A structural rationale for selective stabilization of anti-tumor interactions of 14-3-3 proteins by cotylenin A. J Mol Biol 386(4):913–919
Berggard T, Linse S, James P (2007) Methods for the detection and analysis of protein-protein interactions. Proteomics 7(16):2833–2842
Stauber RH et al (1998) Analysis of intracellular trafficking and interactions of cytoplasmic HIV-1 rev mutants in living cells. Virology 251(1):38–48
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer Science+Business Media LLC
About this protocol
Cite this protocol
Fetz, V., Stauber, R.H., Knauer, S.K. (2018). Translocation Biosensors—Versatile Tools to Probe Protein Functions in Living Cells. In: Johnston, P., Trask, O. (eds) High Content Screening. Methods in Molecular Biology, vol 1683. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-7357-6_12
Download citation
DOI: https://doi.org/10.1007/978-1-4939-7357-6_12
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-7355-2
Online ISBN: 978-1-4939-7357-6
eBook Packages: Springer Protocols